Literature DB >> 1456383

Early diagnosis of severe myoclonic epilepsy in infancy.

M Yakoub1, O Dulac, I Jambaqué, C Chiron, P Plouin.   

Abstract

Of 329 epileptic patients referred in a six year period with the first seizure occurring in the first year of life, 20 met the following criteria: generalized seizures excluding infantile spasms, myoclonic, tonic or absence seizures, at least one afebrile seizure, normal development prior to the first seizure, normal CT scan, and no etiology. Seventeen of these 20 patients developed the full pattern of severe myoclonic epilepsy in infancy (SMEI). This syndrome was recognizable from the second or third seizure in the first year of life, although epileptiform EEG abnormalities were lacking until the age of 11 to over 30 months. Therefore, based on the clinical pattern, the diagnosis of SMEI can be made with quite good reliability by the end of the first year of life.

Entities:  

Mesh:

Year:  1992        PMID: 1456383     DOI: 10.1016/s0387-7604(12)80147-1

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  18 in total

1.  Severe Myoclonic Epilepsy in Infancy - Adult Phenotype with Bradykinesia, Hypomimia, and Perseverative Behavior: Report of Five Cases.

Authors:  P Martin; B Rautenstrauβ; A Abicht; J Fahrbach; S Koster
Journal:  Mol Syndromol       Date:  2011-03-26

Review 2.  SCN1A mutations in Dravet syndrome: impact of interneuron dysfunction on neural networks and cognitive outcome.

Authors:  Alex C Bender; Richard P Morse; Rod C Scott; Gregory L Holmes; Pierre-Pascal Lenck-Santini
Journal:  Epilepsy Behav       Date:  2012-02-16       Impact factor: 2.937

Review 3.  Myoclonus and epilepsies.

Authors:  N Fejerman
Journal:  Indian J Pediatr       Date:  1997 Sep-Oct       Impact factor: 1.967

4.  Diagnosing idiopathic/cryptogenic epilepsy syndromes in infancy.

Authors:  N Sarisjulis; B Gamboni; P Plouin; A Kaminska; O Dulac
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

5.  Occlusive patch therapy for reduction of seizures in Dravet syndrome.

Authors:  Catherine Choi; Nausheen Khuddus; Casey Mickler; Sanjeev Tuli; Sonal Tuli
Journal:  Clin Pediatr (Phila)       Date:  2010-12-02       Impact factor: 1.168

6.  Focal abnormalities detected by 18FDG PET in epileptic encephalopathies.

Authors:  C D Ferrie; M Maisey; T Cox; C Polkey; S F Barrington; C P Panayiotopoulos; R O Robinson
Journal:  Arch Dis Child       Date:  1996-08       Impact factor: 3.791

7.  Neuroimaging and spectroscopy in children with epileptic encephalopathies.

Authors:  A P Parker; C D Ferrie; S Keevil; M Newbold; T Cox; M Maisey; R O Robinson
Journal:  Arch Dis Child       Date:  1998-07       Impact factor: 3.791

8.  Severe myoclonic epilepsy associated with mitochondrial cytopathy.

Authors:  M Castro-Gago; J Eirís; J Fernández-Bustillo; D Escribano; E Pintos; L Monasterio; J Peña
Journal:  Childs Nerv Syst       Date:  1995-11       Impact factor: 1.475

Review 9.  Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome.

Authors:  An-Sofie Schoonjans; Lieven Lagae; Berten Ceulemans
Journal:  Ther Adv Neurol Disord       Date:  2015-11       Impact factor: 6.570

10.  Dravet syndrome.

Authors:  Gemma Incorpora
Journal:  Ital J Pediatr       Date:  2009-09-08       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.